Hepatitis B (krónikus): vizsgálatok itt: India
1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleTAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
- Where
- New Delhi
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- Institute of Liver and Biliary Sciences, India
See details and how to joinNCT05195450